Volume 40, Issue 1 pp. 50-52
Full Access

Distribution of 7-hydroxymethotrexate in human blood

Lars Slørdal

Corresponding Author

Lars Slørdal

Department of Pharmacology

Dept of Pharmacology, Institute of Medical Biology, University of Tromsø, P.O. Box 977, N-9001 Tromsø, Norway.Search for more papers by this author
Georg Sager

Georg Sager

Department of Pharmacology

Search for more papers by this author
Nils-Erik Huseby

Nils-Erik Huseby

Department of Clinical Chemistry, Institute of Medical Biology, University of Tromsø, P.O. Box 977, N-9001 Tromsø, Norway

Search for more papers by this author
Jarle Aarbakke

Jarle Aarbakke

Department of Pharmacology

Search for more papers by this author
First published: January 1988
Citations: 6

Abstract

Abstract— We have examined the in-vitro distribution of 7-hydroxymethotrexate (7-OH-MTX), a cytotoxic metabolite of methotrexate (MTX), in human blood, and its protein binding in serum. The distribution of 7-OH-MTX (10−6 M) in fresh samples of whole blood was studied at 37 °C and pH 7.51 ± 0.05 (mean ± s.d.), and its protein binding was assessed by equilibrium dialysis of serum against Krebs Ringer phosphate buffer at 37 °C and pH 7.41 ± 0.07 (mean ± s.d.). 7-OH-MTX had a mean cell/plasma concentration ratio of 0.03 (range 0–0.27, n = 18). It was extensively bound in human serum, with a bound fraction of 90.4 ± 3.3% (mean ± s.d.) in healthy volunteers (n = 11), and significantly lower, 82.3 ± 4.0% (mean ± s.d.), in hypoalbuminaemic surgical patients (n = 7). The binding of 7-OH-MTX was correlated with serum albumin (HSA) concentrations (r = 0.72, P < 0.0007, n = 18). Blood distribution data support the contention that 7-OH-MTX has a small volume of distribution, and HSA appears to be mainly responsible for the high degree of its protein binding in serum.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.